Pages

23 April 2021

China presses Hong Kongers to accept a Chinese vaccine


Since the middle of March all Hong Kong residents over the age of 30 have been entitled to book a vaccination. They even have the luxury of a choice: between the Pfizer-BioNTech vaccine created in Germany or one produced by Sinovac, a Chinese firm. Yet despite plentiful supply only about 8% of the population have chosen to get a shot. One reason is rock-bottom trust in the government, the product of two years of political turmoil. It is only one way that the dismantling of Hong Kong’s freedoms has made controlling the virus more fraught.

The take-up of vaccinations in Hong Kong lags far behind that in comparable places such as Singapore, where about 20% of people have been vaccinated. A survey carried out in January, before the vaccination drive began, found that only 37% of Hong Kongers wanted a jab. Since then local media have kept count of people who die in the days and weeks after a vaccination, despite copious evidence that vaccination makes death less likely, not more so. Infection rates are fairly low, so people who worry about side effects feel they can afford to put off their shot. On April 15th the government said it was about to start allowing people aged 16-29 to get one.

No comments:

Post a Comment